Literature DB >> 25295758

CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor.

Kejia Cai1, Anup Singh, Harish Poptani, Weiguo Li, Shaolin Yang, Yang Lu, Hari Hariharan, Xiaohong J Zhou, Ravinder Reddy.   

Abstract

In general, multiple components such as water direct saturation, magnetization transfer (MT), chemical exchange saturation transfer (CEST) and aliphatic nuclear Overhauser effect (NOE) contribute to the Z-spectrum. The conventional CEST quantification method based on asymmetrical analysis may lead to quantification errors due to the semi-solid MT asymmetry and the aliphatic NOE located on a single side of the Z-spectrum. Fitting individual contributors to the Z-spectrum may improve the quantification of each component. In this study, we aim to characterize the multiple exchangeable components from an intracranial tumor model using a simplified Z-spectral fitting method. In this method, the Z-spectrum acquired at low saturation RF amplitude (50 Hz) was modeled as the summation of five Lorentzian functions that correspond to NOE, MT effect, bulk water, amide proton transfer (APT) effect and a CEST peak located at +2 ppm, called CEST@2ppm. With the pixel-wise fitting, the regional variations of these five components in the brain tumor and the normal brain tissue were quantified and summarized. Increased APT effect, decreased NOE and reduced CEST@2ppm were observed in the brain tumor compared with the normal brain tissue. Additionally, CEST@2ppm decreased with tumor progression. CEST@2ppm was found to correlate with the creatine concentration quantified with proton MRS. Based on the correlation curve, the creatine contribution to CEST@2ppm was quantified. The CEST@2ppm signal could be a novel imaging surrogate for in vivo creatine, the important bioenergetics marker. Given its noninvasive nature, this CEST MRI method may have broad applications in cancer bioenergetics.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  amide proton transfer (APT); brain tumor; chemical exchange saturation transfer (CEST); creatine; magnetic resonance spectroscopy (MRS); nuclear Overhauser effect (NOE)

Mesh:

Substances:

Year:  2014        PMID: 25295758      PMCID: PMC4257884          DOI: 10.1002/nbm.3216

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  55 in total

1.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST).

Authors:  K M Ward; A H Aletras; R S Balaban
Journal:  J Magn Reson       Date:  2000-03       Impact factor: 2.229

2.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals.

Authors:  A Naressi; C Couturier; I Castang; R de Beer; D Graveron-Demilly
Journal:  Comput Biol Med       Date:  2001-07       Impact factor: 4.589

3.  1H NMR of intact muscle at 11 T.

Authors:  C Arús; M Bárány; W M Westler; J L Markley
Journal:  FEBS Lett       Date:  1984-01-09       Impact factor: 4.124

4.  Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.

Authors:  A Lin; S Bluml; A N Mamelak
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 5.  Epidemiologic impact of children with brain tumors.

Authors:  W A Bleyer
Journal:  Childs Nerv Syst       Date:  1999-11       Impact factor: 1.475

6.  Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids.

Authors:  Peter C M van Zijl; Jinyuan Zhou; Noriko Mori; Jean-Francois Payen; David Wilson; Susumu Mori
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

7.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.

Authors:  Xiaojuan Li; Ying Lu; Andrea Pirzkall; Tracy McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2002-09       Impact factor: 4.813

8.  Amide proton transfer (APT) contrast for imaging of brain tumors.

Authors:  Jinyuan Zhou; Bachchu Lal; David A Wilson; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2003-12       Impact factor: 4.668

9.  Java-based graphical user interface for the MRUI quantitation package.

Authors:  A Naressi; C Couturier; J M Devos; M Janssen; C Mangeat; R de Beer; D Graveron-Demilly
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

10.  Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times.

Authors:  A Ramani; C Dalton; D H Miller; P S Tofts; G J Barker
Journal:  Magn Reson Imaging       Date:  2002-12       Impact factor: 2.546

View more
  84 in total

1.  Improving the detection sensitivity of pH-weighted amide proton transfer MRI in acute stroke patients using extrapolated semisolid magnetization transfer reference signals.

Authors:  Hye-Young Heo; Yi Zhang; Tina M Burton; Shanshan Jiang; Yansong Zhao; Peter C M van Zijl; Richard Leigh; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-06-21       Impact factor: 4.668

2.  Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.

Authors:  Jiaxuan Zhang; Wenzhen Zhu; Rongwen Tain; Xiaohong Joe Zhou; Kejia Cai
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

3.  Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Authors:  Ayan Debnath; Rakesh Kumar Gupta; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

4.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

5.  Separating fast and slow exchange transfer and magnetization transfer using off-resonance variable-delay multiple-pulse (VDMP) MRI.

Authors:  Lin Chen; Xiang Xu; Haifeng Zeng; Kannie W Y Chan; Nirbhay Yadav; Shuhui Cai; Kathryn J Schunke; Nauder Faraday; Peter C M van Zijl; Jiadi Xu
Journal:  Magn Reson Med       Date:  2018-02-05       Impact factor: 4.668

6.  pH-sensitive amide proton transfer effect dominates the magnetization transfer asymmetry contrast during acute ischemia-quantification of multipool contribution to in vivo CEST MRI.

Authors:  Yin Wu; Iris Yuwen Zhou; Dongshuang Lu; Emiri Manderville; Eng H Lo; Hairong Zheng; Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2017-07-21       Impact factor: 4.668

7.  High-sensitivity CEST mapping using a spatiotemporal correlation-enhanced method.

Authors:  Lin Chen; Suyi Cao; Raymond C Koehler; Peter C M van Zijl; Jiadi Xu
Journal:  Magn Reson Med       Date:  2020-06-29       Impact factor: 4.668

8.  Temperature dependence of 1H NMR chemical shifts and its influence on estimated metabolite concentrations.

Authors:  Felizitas C Wermter; Nico Mitschke; Christian Bock; Wolfgang Dreher
Journal:  MAGMA       Date:  2017-07-06       Impact factor: 2.310

9.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Dong-Hoon Lee; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-05-28       Impact factor: 4.668

Review 10.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.